[Progress on the drug therapy for diabetic microangiopathies: PKCbeta inhibitor].
Koya
Daisuke
D
Department of Internal Medicine, Shiga University of Medical Science.
Kashiwagi
Atsunori
A
D000818:Animals; D002986:Clinical Trials as Topic; D003925:Diabetic Angiopathies / Q000188:drug therapy* / Q000209:etiology; D004195:Disease Models, Animal; D006801:Humans; D007211:Indoles / Q000494:pharmacology / Q000627:therapeutic use*; D008301:Maleimides / Q000494:pharmacology / Q000627:therapeutic use*; D011493:Protein Kinase C / Q000037:antagonists & inhibitors* / Q000378:metabolism; D064546:Protein Kinase C beta; D016212:Transforming Growth Factor beta; D042461:Vascular Endothelial Growth Factor A
D007211:Indoles; D008301:Maleimides; D016212:Transforming Growth Factor beta; D042461:Vascular Endothelial Growth Factor A; C099154:ruboxistaurin; D011493:Protein Kinase C; D064546:Protein Kinase C beta